Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for Severe Community Acquired Pneumonia
NCT01998399Phase 2Terminated
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ticagrelor in community acquired pneumonia (CAP). Started Aug 2014; status: terminated.
02
Drugs
ticagrelor
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01998399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998399.